Prevention

Historically, postoperative pulmonary complications have been the most common serious adverse event following upper abdominal surgery, with incidence rates ranging from 10% to 50%.

With about 1 million individuals getting herpes zoster each year in the United States, the best protection against the virus is vaccination.

As this season’s flu continues to drive patients to hospitals in droves, an IV bag shortage and tapped out staffing makes infection control particularly difficult.

The FDA grants Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted whole Zika virus vaccine candidate.

As flu cases continue to rapidly increase this season, school districts around the country have taken to closing schools in order to prevent the spread of the virus.

The fluoroquinolone exhibits activity against both gram-positive and gram-negative pathogens, including methicillin-resistant Staphylococcus aureus, and is available in both intravenous and oral formulations.

Barley Chironda, RPN, CIC, discusses why some health care workers are not practicing good hand hygiene and ways to motivate them to do so.

Dr. Richard Vickers, explains how ridinilazole affected the gut microbiome in participants of a phase 2 study.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

In case you missed them, we've compiled a list of the latest US Food and Drug Administration (FDA) recalls posted this week.

More than $2 billion was invested in research and development relevant to the issue of antimicrobial resistance in 2016 alone.

Can a prior pharmaceutical company president successfully address ever-climbing medication costs in the United States?

As 49 states report widespread flu activity for the second week in a row, researchers at UCLA offer hope in the form of a new flu vaccine candidate.

Analysis finds increased social spending was positively associated with population health measures in Canada at the provincial level.

Glenn Tillotson, PhD, FIDSA, discusses the costs of drug development.

A new article suggests that in order to combat antibiotic resistance in lower- and middle-income countries, particular attention needs to be paid to emerging One Health challenges.

William Schaffner, MD, explains what we can expect for the 2017-2018 flu season and how clinicians can ensure their patients get vaccinated.

A new data analysis suggests that individuals born at the time of a flu pandemic are more susceptible to death in future pandemics.

A total of 22 cases of yellow fever have been confirmed in Minas Gerais since July 2017 and 15 of those individuals have died.

A new study confirms the ribavirin steady-state serum levels that correspond to high rates of efficacy and low adverse events.

Dr. Richard Vickers, discusses how ridinilazole showed superior efficacy for the treatment of C. diff when compared with vancomycin in a phase 2 study.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Richard Haupt, MD, MPH, discusses what is needed to ensure that a future C. diff vaccine is adequately stocked and delivered to wherever individuals show up for vaccination.

Robert Bransfield, MD, DLFAPA, explains how open minds are needed to understand how infections can impact cognitive function and conduct.

SHEA has released expert guidance advising hospitals on when they can safely take patients with multidrug-resistant bacteria off of contact precautions.